Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,730 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) Trial.
Inohara T, Otsuka T, Watanabe Y, Shirai S, Tada N, Yamanaka F, Ueno H, Ohno Y, Tabata M, Suzuyama H, Asami M, Yamawaki M, Izumo M, Yamasaki K, Nishina H, Fuku Y, Mizutani K, Yashima F, Yamamoto M, Hayashida K. Inohara T, et al. Among authors: yamasaki k. Contemp Clin Trials. 2023 Nov;134:107358. doi: 10.1016/j.cct.2023.107358. Epub 2023 Oct 16. Contemp Clin Trials. 2023. PMID: 37852534 Clinical Trial.
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.
Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL 3rd, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ; Evolut Low Risk Trial Investigators. Popma JJ, et al. N Engl J Med. 2019 May 2;380(18):1706-1715. doi: 10.1056/NEJMoa1816885. Epub 2019 Mar 16. N Engl J Med. 2019. PMID: 30883053 Clinical Trial.
Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients　- A Subanalysis of the ENVISAGE-TAVI AF Trial.
Watanabe Y, Hayashida K, Yamamoto M, Yamanaka F, Yamasaki K, Naganuma T, Ohno Y, Yamawaki M, Morioka N, Mizutani K, Tada N, Ueno H, Nishina H, Izumo M, Nakajima Y, Ando K, Takagi K, Kimura T, Sugio K, Dangas G, Van Mieghem NM, Hengstenberg C, Chen C, Jin J, Unverdorben M, Saito S. Watanabe Y, et al. Among authors: yamasaki k. Circ J. 2022 Oct 25;86(11):1756-1763. doi: 10.1253/circj.CJ-22-0093. Epub 2022 Aug 11. Circ J. 2022. PMID: 35965066 Free article. Clinical Trial.
Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry.
Yamamoto M, Yashima F, Shirai S, Tada N, Naganuma T, Yamawaki M, Yamanaka F, Mizutani K, Noguchi M, Ueno H, Takagi K, Ohno Y, Izumo M, Nishina H, Suzuyama H, Yamasaki K, Nishioka K, Hachinohe D, Fuku Y, Otsuka T, Asami M, Watanabe Y, Hayashida K, Ocean-Tavi Investigators OBOT. Yamamoto M, et al. Among authors: yamasaki k. EuroIntervention. 2024 May 10;20(9):579-590. doi: 10.4244/EIJ-D-23-00996. EuroIntervention. 2024. PMID: 38726714 Free article.
Initial Results of Intra-Annular Self-Expandable Valves: Insights From the OCEAN-TAVI Registry.
Shirai S, Yamamoto M, Yashima F, Hioki H, Ryuzaki T, Morofuji T, Naganuma T, Yamanaka F, Mizutani K, Noguchi M, Ueno H, Takagi K, Ohno Y, Izumo M, Nishina H, Suzuyama H, Yamasaki K, Hachinohe D, Fuku Y, Otsuka T, Asami M, Watanabe Y, Hayashida K; OCEAN-TAVI Investigators. Shirai S, et al. Among authors: yamasaki k. JACC Asia. 2024 Jun 11;4(7):536-544. doi: 10.1016/j.jacasi.2024.04.010. eCollection 2024 Jul. JACC Asia. 2024. PMID: 39101119 Free PMC article.
Prospective investigation of calcium score in optical coherence tomography-guided revascularization to identify lesions with low risk for stent under expansion: the CORAL study.
Katagiri Y, Kitani S, Takenouchi G, Suzuki T, Hirai T, Ishikawa K, Kasai Y, Miyazaki M, Yamasaki K, Kuroda K, Hosoi Y, Yamaki M, Yamazaki S, Igarashi Y. Katagiri Y, et al. Among authors: yamasaki k. Cardiovasc Interv Ther. 2024 Jul 17. doi: 10.1007/s12928-024-01028-y. Online ahead of print. Cardiovasc Interv Ther. 2024. PMID: 39020108
Ibuprofen‑derived nitric oxide donors with a high affinity to human serum albumin induce cell death in pancreatic cancer cells through a non‑caspase 3/7‑mediated pathway.
Nishi K, Arimura Y, Suetsugi N, Beppu T, Takasaki K, Tamori A, Kanda R, Imoto S, Murase H, Tsukigawa K, Otagiri M, Yamasaki K. Nishi K, et al. Among authors: yamasaki k. Biomed Rep. 2024 Aug 29;21(5):159. doi: 10.3892/br.2024.1847. eCollection 2024 Nov. Biomed Rep. 2024. PMID: 39268409 Free PMC article.
1,730 results